• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 18-07-2026: Press Release

    18-07-2026 | 08:35 pm

    Alembic Pharma's partner NATCO secured USFDA tentative approval for Olaparib Tablets, a drug with a USD 1.4 billion market. Alembic will distribute, though related litigation is still pending.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited